01/05/2016 05:57:08 1-888-992-3836 (toll free) Free Membership Login

Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
04/26/20164:05PMBWExactech Q1 Revenue Up 6% to $65.3 Million
Net Income of $4.4 Million; Diluted EPS $0.31 vs. $0.29 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue of $65.3 million for the first quarter of 2016, a 6% increase from $61.4 million in the first... More...>>
04/25/20169:20AMBWExactech Receives FDA 510(k) Clearance for Vantage™ Total Ankle
Clearance Marks Company’s Latest Product Development in Extremities Line Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today it has received clearance from the U.S. Food and Drug Administration to market... More...>>
04/12/20169:05AMBWExactech Schedules First Quarter 2016 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its first quarter financial results after the market closes on Tuesday, April 26th, 2016. A copy of the earnings release will be available at http://www.hawkassociates.com... More...>>
03/10/20161:00PMBWExactech Announces Completion of Corporate Integrity Agreement Requirements
Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, announced today that it has completed the requirements of its five-year Corporate Integrity Agreement (CIA) between the Office of Inspector General and the Department of... More...>>
03/03/20169:00AMBWExactech Innovations Presented at 2016 Orthopaedic Research Society Annual Meeting
Studies Include Reverse Shoulder Surgery, Hip and Knee Arthroplasty, and Impact of ExactechGPS® Computer Assisted Technology in Orthopaedic Surgery Exactech Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic materials, will present more than... More...>>
03/01/20169:00AMBWExactech Innovations Simplify the Complexity of Revision Total Joint Replacement
Exactech Unveils New Knee, Hip and Shoulder Revision Systems during AAOS 2016 Annual Meeting, Exhibit #3881 Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologic solutions, announced today its lineup of products to be unveiled at the... More...>>
02/16/20164:05PMBWExactech 2015 Revenue $241.8 Million, Net Income $14.8 Million, EPS $1.04
Q4 Revenue $62.7M, Net Income $4.1M, EPS $0.29 Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today that revenue for 2015 decreased 3% to $241.8 million from $248.4 million in 2014 and 2015 revenue increased 1% on... More...>>
02/05/20163:15PMBWExactech Schedules Fourth Quarter and Year End 2015 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, will release its fourth quarter and year end 2015 financial results after the market closes on Tuesday, February 16th, 2016. A copy of the earnings release will be available at... More...>>
02/01/20164:11PMBWExactech Acquires Australian Distributor
Exactech Australia Becomes Exactech Subsidiary and Ninth Direct Operation Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for extremities, knee, hip, spine and biologics, announced today the acquisition of its independent distribution partner, Exactech Australia Pty Ltd, effective... More...>>
01/04/201610:00AMBWExactech Announces the Sale of Its Dental Biologic Assets to Salvin Dental Specialties
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the sale of substantially all of the assets of its dental biologics business to Salvin Dental Specialties, through its Salvin Regenerative subsidiary. Salvin Dental is a privately... More...>>
12/18/20159:15AMBWExactech Announces Renewal of $150 Million Senior Secured Debt Credit Facility
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the five year renewal and increase of its Senior Secured Revolving Credit Facility to $150 million. J.P. Morgan Securities LLC will act as sole lead arranger and sole bookrunner... More...>>
12/07/20154:43PMBWExactech Announces Stock Repurchase Authorization
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that its board of directors has authorized the company to buy back up to 1.0 million shares of Exactech stock over the next two years. “Based on historical prices for Exactech... More...>>
10/27/20154:05PMBWExactech Q3 2015 Revenue $56.2 Million. Net Income $2.9 Million. Diluted EPS $0.20.
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $56.2 million for the third quarter of 2015, a 3% decrease from $57.9 million in the third quarter of 2014. On a constant currency basis for the quarter, revenue was... More...>>
10/26/201511:36AMBWExactech Innovations Presented at Key Scientific Conference
New Studies Support Company’s Knee, Shoulder and ExactechGPS® Technologies Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today recounted 18 studies presented at key scientific conferences this Fall, including an Equinoxe® shoulder study... More...>>
10/15/20154:05PMBWExactech Announces Third Quarter 2015 Earnings Release Date and Updates Third Quarter Estimates
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, said today the company’s financial results for the third quarter ended September 30, 2015 will be below the company’s previously announced guidance. The company attributed... More...>>
10/13/20159:29AMBWExactech Broadens Spine Portfolio with Launch of Anchored Anterior Cervical Interbody Device at NASS 2015
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the launch of the new Acapella® One Cervical Spacer System with integrated anchors during the North American Spine Society Annual Meeting (NASS) in Chicago, IL, this week. Exactech... More...>>
10/07/20159:30AMBWExactech Announces Successful First Surgery with New Equinoxe® Shoulder Reconstruction Prosthesis
Exactech Enhances Focus on Revision Arthroplasty with Pilot Launch of Three New Revision Systems in Fourth Quarter Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the successful first surgery using its new Equinoxe® Humeral... More...>>
10/02/201511:59AMBWExactech Announces Successful First Surgeries with New Alteon® Monobloc Revision Hip Stem
Exactech Enhances Focus on Revision Arthroplasty with Pilot Launch of Three New Revision Systems in Fourth Quarter Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today successful first surgeries using its new Alteon® Monobloc... More...>>
09/30/201512:50PMBWExactech Announces Successful First Surgeries with New Revision Knee System
Enhances Focus on Revision Arthroplasty with Pilot Launch of Three New Revision Systems in Fourth Quarter Exactech, Inc. (Nasdaq: EXAC), a worldwide developer and producer of bone and joint restoration products, announced today the successful first surgeries performed with its new revision knee system. Designed to provide... More...>>
09/10/201512:00PMBWGlobal Launch of ExactechGPS® Gains Early Surgeon Acceptance
Surgeons Gain Hands-On Experience at Exactech’s First Asia-Pacific Computer-Assisted Surgery Medical Education Courses Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, reported today that surgeons around the world are expressing positive... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:us D:20160501 09:57:09